Research Topics
| Gregg W StoneSummaryAffiliation: Cardiovascular Research Foundation Country: USA Publications
| Collaborators
|
Detail Information
Publications
Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarctionGregg W Stone
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
J Am Coll Cardiol 39:591-7. 2002..We sought to evaluate and validate the ability of the angiographic myocardial blush grade to risk stratify patients after successful angioplasty in acute myocardial infarction (AMI)...
A polymer-based, paclitaxel-eluting stent in patients with coronary artery diseaseGregg W Stone
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York 10022, USA
N Engl J Med 350:221-31. 2004..Restenosis after coronary stenting necessitates repeated percutaneous or surgical revascularization procedures. The delivery of paclitaxel to the site of vascular injury may reduce the incidence of neointimal hyperplasia and restenosis...
Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trialGregg W Stone
Department of Cardiology, Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
JAMA 290:2284-91. 2003....
Usefulness of beta radiation for de novo and in-stent restenotic lesions in saphenous vein graftsGregg W Stone
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 92:312-4. 2003..Clinical and angiographic recurrence rates at 12 months were low, especially in de novo lesions...
Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass graftsGregg W Stone
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, 55 E 59th St, 6th Floor, New York, NY 10022, USA
Circulation 108:548-53. 2003..Whether filter-based catheters, which offer the inherent advantages of maintained perfusion and ease of use, are as effective for this purpose has not been established...
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trialGregg W Stone
The Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, 55 E 59th St, 6th Floor, New York, NY 10022, USA
Circulation 109:1942-7. 2004..The safety and efficacy of the slow-release, polymer-based, paclitaxel-eluting stent after implantation in a broad cross section of de novo coronary lesions at 1 year are unknown...
Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registryGregg W Stone
Cardiovascular Research Foundation and Lenox Hill Hospital, 55 East 59th Street, 6th Floor, New York, NY 10022, USA
J Am Coll Cardiol 41:1940-5. 2003..We sought to examine contemporary utilization patterns and clinical outcomes in patients with acute myocardial infarction (AMI) requiring intra-aortic balloon pump (IABP) counterpulsation...
Long-term care after percutaneous coronary intervention: focus on the role of antiplatelet therapyGregg W Stone
Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY 10022, USA
Mayo Clin Proc 81:641-52. 2006..In this context, dual antiplatelet therapy (aspirin plus clopidogrel) is recommended for at least 12 months after PCI for prophylaxis of future atherothrombotic events...
Safety and efficacy of a novel device for treatment of thrombotic and atherosclerotic lesions in native coronary arteries and saphenous vein grafts: results from the multicenter X-Sizer for treatment of thrombus and atherosclerosis in coronary applicationGregg W Stone
The Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10021, USA
Catheter Cardiovasc Interv 58:419-27. 2003..0%, and any MACE in 6.0%. We conclude that the use of the X-Sizer prior to percutaneous intervention is safe in high-risk vein grafts and thrombotic lesions and results in a low rate of adverse events compared to historical controls...
Distal filter protection during saphenous vein graft stenting: technical and clinical correlates of efficacyGregg W Stone
The Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY 10022, USA
J Am Coll Cardiol 40:1882-8. 2002..The aim of this study was to evaluate the clinical, angiographic, and technical factors related to successful stenting of diseased saphenous vein grafts (SVGs) using a novel filter-based distal protection device...
Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteriesGregg W Stone
Cardiovascular Research Foundation and Lenox Hill Hospital, New York, New York 10022, USA
J Am Coll Cardiol 42:2007-13. 2003....
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarctionGregg W Stone
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
N Engl J Med 346:957-66. 2002..When used in combination with PTCA, coronary stenting and platelet glycoprotein IIb/IIIa inhibitors may further improve outcomes...
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationaleGregg W Stone
Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY 10022, USA
Am Heart J 148:764-75. 2004..Pilot trials suggest that the thrombin-specific anticoagulant bivalirudin may improve clinical outcomes in ACS...
A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusionsGregg W Stone
Cardiovascular Research Foundation, New York, New York 10021, USA
J Am Coll Cardiol 39:1581-7. 2002..We sought to evaluate the safety and efficacy of percutaneous transmyocardial revascularization (PTMR) in patients with refractory angina caused by one or more chronic total occlusions (CTOs) of a native coronary artery...
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET TrialGregg W Stone
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
Circulation 105:2347-54. 2002..Also unknown is whether the acuity of the presenting clinical syndrome, which may affect the degree of platelet inhibition required or achieved, influences the response to different antiplatelet agents...
Primary angioplasty versus "earlier" thrombolysis--time for a wake-up callGregg W Stone
Lenox Hill Heart and Vascular Institute, Cardiovascular Research Foundation, New York City, NY 10022, USA
Lancet 360:814-6. 2002
Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY)Roxana Mehran
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York 10032, USA
JACC Cardiovasc Interv 2:748-57. 2009....
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trialEugenia Nikolsky
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
J Am Coll Cardiol 54:1293-302. 2009..We assessed the incidence, predictors, and outcomes of gastrointestinal bleeding (GIB) in patients with acute coronary syndromes (ACS)...
A risk score to predict bleeding in patients with acute coronary syndromesRoxana Mehran
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York 10032, USA
J Am Coll Cardiol 55:2556-66. 2010..The aim of this study was to develop a practical risk score to predict the risk and implications of major bleeding in acute coronary syndromes (ACS)...
Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial)Kenichi Tsujita
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 105:1385-94. 2010..Paradoxically, in this post hoc analysis, the reductions in major bleeding and mortality in ST elevation myocardial infarction afforded by bivalirudin occurred primarily in patients without baseline anemia...
Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial)Alexandra J Lansky
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 103:1196-203. 2009..In women, bivalirudin monotherapy compared with a GPI-based strategy resulted in significantly decreased bleeding but similar rates of 1-year composite ischemia and mortality...
Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent TrialsHiroshi Doi
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
JACC Cardiovasc Interv 2:1269-75. 2009..We investigated the predictive value of the intravascular ultrasound (IVUS) measured post-intervention minimum stent area (MSA) on 9-month follow-up paclitaxel-eluting stent (PES) patency compared with bare-metal stents (BMS)...
Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial InAdam J Saltzman
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
JACC Cardiovasc Interv 4:1011-9. 2011..This study sought to investigate the impact of chronic kidney disease (CKD) in patients undergoing percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) with different antithrombotic strategies...
Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial)Kenji Goto
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 108:1387-94. 2011..Bivalirudin monotherapy compared to UFH plus a GPI decreased major bleeding regardless of smoking status but may have different effects on individual components of ischemic events...
The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationaleRoxana Mehran
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10032, USA
Am Heart J 156:44-56. 2008..Newer pharmacologic agents and drug-eluting stents may address both of these issues...
Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarctionGeorge D Dangas
Cardiovascular Institute, Mount Sinai Medical Center, One Gustave L Levy Place, New York, NY 10029, USA
Circulation 123:1745-56. 2011..Concerns persist regarding the risk of stent thrombosis in the setting of primary percutaneous coronary intervention for ST-segment elevation myocardial infarction...
Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary interventionEugenia Nikolsky
Cardiovascular Research Foundation, and Lenox Hill Heart and Vascular Institute, New York, New York, USA
Am J Cardiol 94:300-5. 2004..Contrast-induced nephropathy was among the independent predictors of a 1-year mortality rate (OR 2.75, p <0.001)...
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trialRoxana Mehran
Columbia University Medical Center New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY, USA
Lancet 374:1149-59. 2009..Here, we assess whether these initial benefits were maintained at 1 year of follow-up...
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent Bimmer E Claessen
New York Presbyterian Hospital, Columbia University, New York, NY, USA
JACC Cardiovasc Interv 4:1209-15. 2011..The aim of this study was to investigate the impact of reference vessel diameter (RVD) and lesion length (LL) on the relative safety and efficacy of everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES)...
Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker's paradox revisitedGiora Weisz
Cardiovascular Research Foundation and Center for Interventional Therapy, New York, NY, USA
Am Heart J 150:358-64. 2005..The deleterious effects of smoking are expressed in the occurrence of AMI nearly a decade earlier than in nonsmokers, with similar age-adjusted risk, mandating intensive primary and secondary cigarette-cessation efforts...
Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial)Eugenia Nikolsky
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 99:1055-61. 2007..03, 95% CI 1.00 to 1.06, p = 0.055) at 1 year. In conclusion, a higher baseline platelet count in patients with AMI is a powerful independent predictor of death and reinfarction within the first year after primary PCI...
Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent eraTereza Pucelikova
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
Am J Cardiol 101:63-8. 2008..025). In conclusion, our data show that patients with SVG lesions remain a high-risk subgroup with worse outcomes after percutaneous coronary intervention compared with native vessel disease even in the era of drug-eluting stents...
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trialGregg W Stone
New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10022, USA
Lancet 377:2193-204. 2011..Primary results of the HORIZONS-AMI trial have been previously reported. In this final report, we aimed to assess 3-year outcomes...
Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) TrialEugenia Nikolsky
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10032, USA
JACC Cardiovasc Interv 2:624-32. 2009..We sought to determine the relationship between red blood cell (RBC) transfusion and clinical outcomes in patients undergoing primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI)...
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarctionGregg W Stone
Columbia University Medical Center and New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY 10022, USA
N Engl J Med 360:1946-59. 2009....
Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trialAlexandra J Lansky
Columbia University Medical Center, Department of Cardiology, Cardiovascular Research Foundation, New York, New York 10022, USA
Catheter Cardiovasc Interv 72:917-24. 2008..The aim of this article is to examine whether clopidogrel and ticlopidine treatments produce similar clinical outcomes for patients receiving primary stenting for acute myocardial infarction (AMI)...
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trialGregg W Stone
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
Lancet 369:907-19. 2007..The aim of this study was to assess anticoagulation with the direct thrombin inhibitor bivalirudin during percutaneous coronary intervention in individuals with moderate and high-risk acute coronary syndromes...
Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) TrialEugenia Nikolsky
Cardiovascular Research Foundation, New York, New York 10022, USA
J Am Coll Cardiol 44:547-53. 2004..26; p = 0.048) and one-year mortality (hazard ratio, 2.38; p = 0.016). CONCLUSIONS: Anemia at baseline in patients with AMI undergoing primary PCI is common, and is strongly associated with adverse outcomes and increased mortality...
Intravascular ultrasound comparison of the retrograde versus antegrade approach to percutaneous intervention for chronic total coronary occlusionsKenichi Tsujita
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
JACC Cardiovasc Interv 2:846-54. 2009..We sought to evaluate the results of the antegrade versus retrograde chronic total occlusion (CTO) technique with intravascular ultrasound (IVUS) imaging...
Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trialGeorge Dangas
Columbia University Medical Center, New York, New York Cardiovascular Research Foundation, New York, New York 10022, USA
J Am Coll Cardiol 54:1438-46. 2009....
Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intRoxana Mehran
Department of Cardiology, Mount Sinai Medical Center, New York, New York, USA
JACC Cardiovasc Interv 4:654-64. 2011..This study sought to develop a risk score predictive of bleeding in patients undergoing percutaneous coronary intervention (PCI) and to investigate the impact of bleeding on subsequent mortality...
Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial ProgramGregg W Stone
Department of Cardiology, Columbia University, Medical Center New York Presbyterian Hospital, New York, New York 10022, USA
JACC Cardiovasc Interv 4:530-42. 2011..These studies sought to evaluate the clinical outcomes of the slow-release Taxus paclitaxel-eluting stent (PES) versus an otherwise identical bare-metal stent (BMS)...
Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent)Stephen G Ellis
Cleveland Clinic, Department of Cardiology, Cleveland, Ohio 44195, USA
JACC Cardiovasc Interv 2:1248-59. 2009....
Impact of thienopyridine administration prior to primary stenting in acute myocardial infarctionLeRoy E Rabbani
Columbia University Medical Center, Cardiovascular Research Foundation, New York, New York 10032, USA
J Interv Cardiol 22:378-84. 2009....
Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasoundMasashi Kimura
The Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 98:436-42. 2006..Although most ISAs after SES implantation do not resolve completely, the incidence of restenosis or thrombosis is not affected...
Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trialGregg W Stone
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
JAMA 298:2497-506. 2007....
An evaluation of fluoroscopy time and correlation with outcomes after percutaneous coronary interventionEugenia Nikolsky
Columbia University Medical Center and the Cardiovascular Research Foundation, New York City, NY 10022, USA
J Invasive Cardiol 19:208-13. 2007..We evaluated short-term prognosis and resource utilization of consecutive patients treated with percutaneous coronary intervention (PCI) as a function of fluoroscopy time...
Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaqueKenichi Fujii
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
Am J Cardiol 95:355-9. 2005..Plaque rupture morphology is associated with higher periprocedural CK-MB release and worse 1-year clinical outcome in patients treated with coronary stenting...
Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantationHideo Takebayashi
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
Circulation 110:3430-4. 2004..01 and P<0.01), minimum lumen area (P<0.01 and P<0.01), and IH thickness (P<0.01 and P<0.01). CONCLUSIONS: The number and distribution of stent struts affect the amount of neointima after SES implantation...
Outcomes of patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trialsJacob A Doll
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, USA
J Interv Cardiol 22:453-9. 2009..The lack of a specific counteragent to bivalirudin may complicate the management of patients with coronary artery (CA) perforation during percutaneous coronary intervention (PCI)...
Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trialGeorge D Dangas
Department of Cardiology, Mount Sinai Medical Center, New York, New York 10029, USA
J Am Coll Cardiol 59:1752-9. 2012....
5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trialGregg W Stone
Department of Medicine, Division of Cardiology, Columbia University, Medical Center New York Presbyterian Hospital, Cardiovascular Research Foundation, New York 10022, USA
JACC Cardiovasc Interv 4:300-9. 2011..We sought to evaluate the utility of the JOSTENT polytetrafluoroethylene (PTFE) stent-graft (Jomed GmbH, Rangendingen, Germany) in patients with diseased saphenous vein grafts (SVGs) undergoing percutaneous coronary intervention (PCI)...
Bivalirudin during primary PCI in acute myocardial infarctionGregg W Stone
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
N Engl J Med 358:2218-30. 2008..The safety and efficacy of bivalirudin in high-risk patients are unknown...
Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trialAlexandra J Lansky
Columbia University Medical Center, New York, NY 10022, USA
Circ Cardiovasc Interv 3:308-16. 2010..We sought to identify the clinical and angiographic predictors of cardiac ischemic events in patients with ACSs treated with an early invasive strategy...
Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventionsEugenia Nikolsky
Cardiovascular Research Foundation, New York, NY 10022, USA
Am J Cardiol 93:1536-9. 2004..These 2 conditions are associated with adverse in-hospital and 1-year outcomes and independently predict early and 1-year mortality...
Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound studyKenichi Fujii
Cardiovascular Research Foundation, Columbia University Medical Center, 55 East 59th Street, New York, NY 10022, USA
J Am Coll Cardiol 45:995-8. 2005..03) and a significant residual reference segment stenosis (p = 0.02). CONCLUSIONS: Stent underexpansion and residual reference segment stenosis are associated with stent thrombosis after successful SES implantation...
Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trialPhilippe Genereux
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
EuroIntervention 7:905-16. 2011..There is a paucity of data comparing the TR approach with the TF approach in patients with STEMI treated with primary PCI and contemporary anticoagulant regimens...
Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trialAlexandra J Lansky
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
Catheter Cardiovasc Interv 74:719-27. 2009..We evaluated the role of gender on clinical and angiographic results of the everolimus-eluting stent in the SPIRIT III trial...
Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stentsBimmer E Claessen
Cardiovascular Research Foundation, Clinical Trial Center, New York, New York, USA
JACC Cardiovasc Interv 4:974-81. 2011..This study sought to assess the impact of intravascular ultrasound (IVUS)-guided versus angiography-guided drug-eluting stent (DES) implantation...
Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosisYoung Hak Kim
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 101:801-6. 2008..However, bifurcation stenosis remains a significant predictor of unfavorable clinical outcome...
Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialKenji Goto
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
JACC Cardiovasc Interv 4:769-77. 2011....
Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantationXuebo Liu
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
JACC Cardiovasc Interv 2:997-1004. 2009..We used intravascular ultrasound (IVUS) to assess incidence, predictors, morphology, and angiographic findings of edge dissections after drug-eluting stent (DES) implantation...
Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery LGregg W Stone
Columbia University Medical Center, Cardiovascular Research Foundation, 111 E 59th St, 11th Floor, New York, NY 10022, USA
Circulation 119:680-6. 2009..The safety and efficacy of EES after 1 year have not been reported...
Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials)Jiro Aoki
Columbia University Medical Center, New York, New York, USA
Am J Cardiol 102:1009-16. 2008..In conclusion, neointimal proliferation was less prominent and expansive vessel remodeling was more prominent after PES than BMS implantation, independent of the severity of renal dysfunction...
Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trialJiro Aoki
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
Circulation 119:687-98. 2009..The clinical and angiographic predictors of early (<30 days) stent thrombosis (ST) have not been reported in high-risk patients with acute coronary syndromes...
Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protectionDale T Ashby
Lenox Hill Heart and Vascular Institute, New York, New York, USA
J Am Coll Cardiol 41:749-52. 2003..It appears that distal embolic protection may not be necessary during PCI of ISR lesions in degenerated SVGs...
Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trialsJiro Aoki
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York 10022, USA
JACC Cardiovasc Interv 1:161-7. 2008....
Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteriesDale T Ashby
Cardiovascular Research Foundation, Lenox Hill Heart and Vascualr Institute, New York, New York 10022, USA
Am J Cardiol 89:1162-6. 2002..A stenting strategy for proximal LAD stenoses appears to attenuate the differences of clinical restenosis noted after non-stent PCI...
Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosisKazuyuki Shirai
Cardiovascular Research Foundation, Lenox Hill Hospital, New York, New York 10022, USA
Am J Cardiol 92:1409-13. 2003..In matched lesions, beta and gamma VBT achieved similar reductions in treated segment restenosis and recurrent lesion length compared with placebo...
Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound studyIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
J Am Coll Cardiol 42:1900-5. 2003..Increased periprocedural CK-MB release appears as a trade-off for optimal stent implantation and lower clinical restenosis...
Bivalirudin for patients with acute coronary syndromesGregg W Stone
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
N Engl J Med 355:2203-16. 2006..We evaluated the role of thrombin-specific anticoagulation with bivalirudin in such patients...
Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)Albert W Chan
Department of Cardiology, Ochsner Clinic Foundation, New Orleans, Louisiana, USA
J Am Coll Cardiol 42:1188-95. 2003..CONCLUSIONS: Among patients undergoing coronary stent placement with aspirin and a GP IIb/IIIa inhibitor, clopidogrel pretreatment is associated with a reduction of death and MI irrespective of the type of GP IIb/IIIa inhibitor used...
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stentsGregg W Stone
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
N Engl J Med 356:998-1008. 2007..Such studies have been inconclusive because of their insufficient size, the use of historical controls, a limited duration of follow-up, and a lack of access to original source data...
Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial)Eugenia Nikolsky
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 95:709-15. 2005..Paclitaxel-eluting stents attenuate the increased risk associated with obesity, such that the intermediate-term prognosis after percutaneous coronary intervention is independent of weight...
Impact of gender and age on in vivo virtual histology-intravascular ultrasound imaging plaque characterization (from the global Virtual Histology Intravascular Ultrasound [VH-IVUS] registry)Jie Qian
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 103:1210-4. 2009....
Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudyKenji Goto
Cardiovascular Research Foundation, 111 E 59th St, 11th Floor, New York, NY 10022, USA
Circulation 121:853-62. 2010..We sought to assess the predictors of adverse cardiac events in patients with acute coronary syndrome assigned to medical management...
Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery diseaseAlexandra J Lansky
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
J Am Coll Cardiol 45:1180-5. 2005..28 [95% CI 0.11 to 0.74], p = 0.01). CONCLUSIONS: The benefits of the paclitaxel-eluting stent in reducing clinical and angiographic restenosis are generalizable to women...
Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarctionEugenia Nikolsky
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 96:474-81. 2005..0% vs 3.9%, p = 0.03) in patients who developed thrombocytopenia. In conclusion, thrombocytopenia that develops after primary PCI for AMI, although uncommon, is associated with increased hemorrhagic complications and decreased survival...
Update on drug-eluting coronary stentsNicholas N Kipshidze
Department of Interventional Cardiac and Vascular Services, Lenox Hill Hospital, New York, NY 10021, USA
Expert Rev Cardiovasc Ther 3:953-68. 2005..Recent advances in vascular gene transfer have also demonstrated potential new treatment modalities for cardiovascular disease, particularly in the treatment of vascular restenosis...
Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trialFrederick Feit
Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York, USA
J Am Coll Cardiol 51:1645-52. 2008..We sought to evaluate clinical outcomes of patients with diabetes mellitus in the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial, overall and by treatment arm...
Non-ST-elevation acute coronary syndromesGregg W Stone
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 1022, USA
Lancet 369:801-3. 2007
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trialGregg W Stone
Columbia University Medical Center, The Cardiovascular Research Foundation, 111 E 59th St, 11th Floor, New York, NY 10022, USA
JAMA 299:1903-13. 2008....
Relation between the degree of procedural anticoagulation and complications after coronary stent implantationDale T Ashby
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 92:319-22. 2003..High levels of procedural anticoagulation with heparin were found to increase hemorrhagic complications without improving clinical or angiographic outcomes...
Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary arteryGeorge Dangas
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
J Am Coll Cardiol 45:1186-92. 2005..Notably, the need for bypass graft surgery due to restenosis is reduced after TAXUS stent implantation in LAD lesions...
New-device angioplasty in women: clinical outcome and predictors in a 7,372-patient registryAlexandra J Lansky
Cardiac Catheterization Laboratory and the Women s Cardiac Health Initiative, Lenox Hill Hospital, New York City, NY 10022, USA
Epidemiology 13:S46-51. 2002..To gain insight into the outcome of women after new-device angioplasty, we reviewed the early and late clinical outcome of 7,372 patients undergoing new-device angioplasty between 1991 and 1996 at the Washington Hospital Center...
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery diseaseGregg W Stone
Columbia University Medical Center New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY 10022, USA
N Engl J Med 362:1663-74. 2010..Previous studies have established the superiority of coronary everolimus-eluting stents over paclitaxel-eluting stents with respect to angiographic findings. However, these trials were not powered for superiority in clinical end points...
Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitorsIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 89:976-9. 2002
Successful use of the frontrunner catheter in the treatment of in-stent coronary chronic total occlusionsYi-ming Yang
Columbia University Medical Center and Cardiovascular Research Foundation, 161 Fort Washington Avenue, New York, NY 10032, USA
Catheter Cardiovasc Interv 63:462-8. 2004..TIMI 3 flow was achieved in all target vessels after further balloon angioplasty or stenting. The Frontrunner device is a safe and effective tool in the treatment of CTOs from ISR...
The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary interventionAdam J Saltzman
Cardiovascular Medicine and the Center for Interventional Vascular Therapy, Columbia University Medical Center, 161 Fort Washington Avenue, New York, NY, 10032, USA
J Invasive Cardiol 22:2-6. 2010..We sought to compare the efficacy of tirofiban and abciximab on platelet inhibition as well as their effects of platelet inhibition on C-reactive protein levels during percutaneous coronary intervention (PCI)...
Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteriesIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 92:1171-6. 2003..Therefore, there does not appear to be any "downside" to aggressive stent implantation strategies in small vessels. In contrast, IVUS allows maximization of final lumen dimensions to minimize clinical restenosis...
Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trialGregg W Stone
Department of Cardiology, Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY 10032, USA
JAMA 294:1215-23. 2005..Compared with bare metal stents, drug-eluting stents reduce restenosis in noncomplex lesions. The utility of drug-eluting stents has not been evaluated in more difficult stenoses...
Impact and determinants of left ventricular function in patients undergoing primary percutaneous coronary intervention in acute myocardial infarctionAmir Halkin
Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 96:325-31. 2005..Simple clinical and angiographic features readily available at the time of primary angioplasty also predict convalescent LVEF and are thus of prognostic utility...
Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowingsJiro Aoki
Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, NY, USA
Am J Cardiol 101:58-62. 2008..In conclusion, the incidence of DES and BMS overlap stenting is rare in daily practice, but this procedure is associated with a high rate of target vessel revascularization...
Effect of prolonged thienopyridine use after drug-eluting stent implantation (from the TAXUS landmark trials data)Gregg W Stone
The Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 102:1017-22. 2008....
Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitusMasashi Kimura
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 101:1263-8. 2008....
Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndromeEduardo Missel
Cardiovascular Research Foundation, Columbia University Medical Center, New York, NY, USA
Am J Cardiol 101:573-8. 2008..01) than patients with no predictors. In conclusion, VH-IVUS analysis showed that the percentage of NC and its ratio to DC in diseased coronary segments are positively associated with a high-risk ACS presentation...
Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk scoreAmir Halkin
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
J Am Coll Cardiol 45:1397-405. 2005..Of note, measurement of baseline left ventricular function is the single most powerful predictor of survival and should be incorporated into risk score models...
Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarctionCostantino O Costantini
Cardiovascular Research Foundation and Lenox Hill Hospital, New York, New York, USA
J Am Coll Cardiol 44:305-12. 2004..Neither stents nor GP IIb/IIIa inhibitors significantly enhance myocardial perfusion compared to balloon angioplasty alone, underlying the similar long-term mortality with these different mechanical reperfusion strategies...
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trialGregg W Stone
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
JAMA 297:591-602. 2007..The preferred approach is undetermined...
Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%Makoto Hirose
Cardiovascular Research Foundation, New York, NY 10021, USA
Am J Cardiol 92:141-5. 2003..7) were similar. Negative remodeling is frequently observed in lesions with intermediate stenosis. This suggests that negative remodeling occurs early in lesion formation...
Polymer-based paclitaxel-eluting stents in percutaneous coronary intervention: a review of the TAXUS trialsAmir Halkin
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, 55 E. 59th Street, New York City, NY 10022, USA
J Interv Cardiol 17:271-82. 2004..5-3.75 mm in diameter. Additional trials in the TAXUS program are currently examining the role of slow and moderate rate-release polymer-based, paclitaxel-eluting stents in a broader range of clinical settings and lesion subsets...
